Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
40.2M
-
Number of holders
-
71
-
Total shares
-
15.3M
-
Shares change
-
+6M
-
Total reported value, excl. options
-
$255M
-
Value change
-
+$100M
-
Put/Call ratio
-
0.29
-
Number of buys
-
53
-
Number of sells
-
-13
-
Price
-
$16.68
Significant Holders of RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) as of Q1 2023
73 filings reported holding RXST - RxSight, Inc. - Common Stock, $0.001 par value per share as of Q1 2023.
RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 40.2M outstanding shares and own 38.04% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (3.05M shares), Artisan Partners Limited Partnership (2.65M shares), BlackRock Inc. (1.25M shares), ORBIMED ADVISORS LLC (1.2M shares), VANGUARD GROUP INC (1.02M shares), NEXT CENTURY GROWTH INVESTORS LLC (877K shares), MILLENNIUM MANAGEMENT LLC (683K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (470K shares), Parkman Healthcare Partners LLC (428K shares), and GEODE CAPITAL MANAGEMENT, LLC (399K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.